Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $22,573 - $25,116
-108 Reduced 7.32%
1,368 $298,000
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $10,279 - $11,819
52 Added 3.65%
1,476 $335,000
Q3 2023

Nov 14, 2023

SELL
$201.05 - $221.7 $8,645 - $9,533
-43 Reduced 2.93%
1,424 $286,000
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $17,378 - $19,789
-82 Reduced 5.29%
1,467 $354,000
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $4,266 - $5,156
20 Added 1.31%
1,549 $355,000
Q4 2022

Feb 14, 2023

BUY
$203.72 - $248.97 $18,742 - $22,905
92 Added 6.4%
1,529 $359,000
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $4,915 - $6,292
-24 Reduced 1.64%
1,437 $294,000
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $5,560 - $7,224
26 Added 1.81%
1,461 $342,000
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $15,069 - $17,294
-58 Reduced 3.88%
1,435 $378,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $11,950 - $13,825
44 Added 3.04%
1,493 $469,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $824 - $925
3 Added 0.21%
1,449 $408,000
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $52,892 - $58,409
-210 Reduced 12.68%
1,446 $399,000
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $45,278 - $56,361
221 Added 15.4%
1,656 $422,000
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $248,403 - $284,964
1,329 Added 1253.77%
1,435 $292,000
Q3 2020

Dec 16, 2020

SELL
$167.03 - $201.3 $187,908 - $226,462
-1,125 Reduced 91.39%
106 $20,000
Q3 2020

Dec 16, 2020

SELL
$167.03 - $201.3 $42,258 - $50,928
-253 Reduced 17.05%
1,231 $232,000
Q3 2020

Nov 13, 2020

BUY
$167.03 - $201.3 $31,735 - $38,247
190 Added 14.68%
1,484 $279,000
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $146,623 - $236,077
1,294 New
1,294 $215,000
Q1 2020

May 06, 2020

SELL
$104.32 - $195.28 $146,465 - $274,173
-1,404 Closed
0 $0
Q4 2019

Jan 28, 2020

SELL
$163.48 - $173.61 $12,424 - $13,194
-76 Reduced 5.14%
1,404 $238,000
Q3 2019

Oct 31, 2019

BUY
$159.77 - $178.1 $5,751 - $6,411
36 Added 2.49%
1,480 $249,000
Q2 2019

Jul 25, 2019

BUY
$144.16 - $172.9 $15,713 - $18,846
109 Added 8.16%
1,444 $249,000
Q1 2019

May 09, 2019

BUY
$123.7 - $156.3 $165,139 - $208,660
1,335 New
1,335 $204,000
Q4 2018

Jan 30, 2019

SELL
$120.82 - $174.09 $184,008 - $265,139
-1,523 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$167.67 - $188.27 $13,581 - $15,249
81 Added 5.62%
1,523 $264,000
Q2 2018

Jul 24, 2018

SELL
$160.33 - $189.41 $12,505 - $14,773
-78 Reduced 5.13%
1,442 $259,000
Q1 2018

May 04, 2018

BUY
$161.53 - $178.11 $8,399 - $9,261
52 Added 3.54%
1,520 $246,000
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $217,249 - $240,678
1,468
1,468 $234,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.